Artivion
AORT
Performance
About Artivion
Artivion specializes in cardiovascular medical devices focused on diseases of the aorta. The company collaborates with cardiac and vascular surgeons to develop innovative, life-changing aortic-centric technologies and products across global markets. Its portfolio includes aortic valve solutions, aortic arch remodeling systems, thoracoabdominal stent grafts, and related allografts and ancillary materials. Headquartered in the United States, Artivion serves physicians and patients worldwide with a focus on improving surgical outcomes in aortic disease.
Recent News
Artivion Closes Endospan Buyout to Acquire Recently Approved Heart Device
AirSculpt Technologies Inc (AIRS) Q4 2025 Earnings Call Transcript
Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
US FDA Reissues Cybersecurity Guidance to Reflect QMSR Transition and ISO 13485 Alignment
Walmart, Coca‑Cola and McDonald’s Topped as Buy‑and‑Hold Dividend Picks